Advanced Pancreatic Adenocarcinoma With Complete Response to Chemoimmunotherapy: A Case Report and Single‐Cell Profiling
Cancer Science · 20.11.2026
DOI: 10.1111/cas.70599 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Science, online erschienen am 20.11.2026. Verfasst von Xinchen Lu und 8 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, especially in unresectable disease. We report a patient with metastatic PDAC who achieved durable complete remission after PD‐1 blockade combined with gemcitabine and albumin‐bound paclitaxel and remains disease‐free 4 years after diagnosis. To explore the immune basis of this response, we performed single‐cell RNA sequencing of peripheral blood mononuclear cells from seven patients receiving the same regimen. Responders showed enrichment of terminally differentiated CD8 + T (Temra) and CD4 ISG + T helper (Th) cells compared with nonresponders. Across independent cohorts, these two programs were positively correlated, suggesting coordinated immune activation during effective therapy. Predicted ligand–target interactions were linked to cytotoxic and immune activation pathways. These findings suggest that coordinated expansion of CD4 + ISG + Th and CD8 + Temra cells are associated with durable chemoimmunotherapy responses in PDAC and support peripheral blood immune profiling as a minimally invasive monitoring strategy. Trial Registration: ClinicalTrials.gov identifier: NCT05201729
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lu, X., Liu, Z., Liu, C., Gao, L., Zhang, B., Ran, T., Zhang, Y., Zhou, C., & Zou, D. (2026). Advanced Pancreatic Adenocarcinoma With Complete Response to Chemoimmunotherapy: A Case Report and Single‐Cell Profiling. Cancer Science. https://doi.org/10.1111/cas.70599
Vancouver
Lu X, Liu Z, Liu C, Gao L, Zhang B, Ran T, et al. Advanced Pancreatic Adenocarcinoma With Complete Response to Chemoimmunotherapy: A Case Report and Single‐Cell Profiling. Cancer Science. 2026. doi:10.1111/cas.70599
BibTeX
@article{Lu2026,
author = {Lu, Xinchen and Liu, Zonghao and Liu, Chenxiao and Gao, Lili and Zhang, Benyan and Ran, Taojing and Zhang, Yao and Zhou, Chunhua and Zou, Duowu},
title = {Advanced Pancreatic Adenocarcinoma With Complete Response to Chemoimmunotherapy: A Case Report and Single‐Cell Profiling},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70599}
}
EUVIMED